Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

210 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy.
Legrand-Abravanel F, Colson P, Leguillou-Guillemette H, Alric L, Ravaux I, Lunel-Fabiani F, Bouviers-Alias M, Trimoulet P, Chaix ML, Hézode C, Foucher J, Fontaine H, Roque-Afonso AM, Gassin M, Schvoerer E, Gaudy C, Roche B, Doffoël M, D'Alteroche L, Vallet S, Baazia Y, Pozzetto B, Thibault V, Nousbaum JB, Roulot D, Coppere H, Poynard T, Payan C, Izopet J. Legrand-Abravanel F, et al. Among authors: foucher j. J Med Virol. 2009 Dec;81(12):2029-35. doi: 10.1002/jmv.21583. J Med Virol. 2009. PMID: 19856464 Free article.
Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C.
de Lédinghen V, Trimoulet P, Winnock M, Foucher J, Bourlière M, Desmorat H, Canva V, Capron D, Lévy S, Mion F, Mannant PR, Chêne G, Fleury H, Couzigou P, Bernard PH; French Multicenter Study Group. de Lédinghen V, et al. Among authors: foucher j. J Hepatol. 2002 May;36(5):672-80. doi: 10.1016/s0168-8278(02)00026-0. J Hepatol. 2002. PMID: 11983451 Clinical Trial.
Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin.
Bronowicki JP, Ouzan D, Asselah T, Desmorat H, Zarski JP, Foucher J, Bourlière M, Renou C, Tran A, Melin P, Hézode C, Chevalier M, Bouvier-Alias M, Chevaliez S, Montestruc F, Lonjon-Domanec I, Pawlotsky JM. Bronowicki JP, et al. Among authors: foucher j. Gastroenterology. 2006 Oct;131(4):1040-8. doi: 10.1053/j.gastro.2006.07.022. Epub 2006 Jul 24. Gastroenterology. 2006. PMID: 17030174 Clinical Trial.
Outbreak of hepatitis C virus infection during sclerotherapy of varicose veins: long-term follow-up of 196 patients (4535 patient-years).
de Lédinghen V, Trimoulet P, Mannant PR, Dumas F, Champbenoît P, Baldit C, Foucher J, Faure M, Vergniol J, Castéra L, Bertet J, Fleury H, Couzigou P, Bernard PH. de Lédinghen V, et al. Among authors: foucher j. J Hepatol. 2007 Jan;46(1):19-25. doi: 10.1016/j.jhep.2006.07.029. Epub 2006 Sep 22. J Hepatol. 2007. PMID: 17030451
Hepatitis B virus genotypes: a retrospective survey in Southwestern France, 1999-2004.
Trimoulet P, Boutonnet M, Winnock M, Faure M, Loko MA, De Lédinghen V, Bernard PH, Castéra L, Foucher J, Dupon M, Ragnaud JM, Lafon ME, Couzigou P, Dabis F, Fleury H, Neau D. Trimoulet P, et al. Among authors: foucher j. Gastroenterol Clin Biol. 2007 Dec;31(12):1088-94. doi: 10.1016/s0399-8320(07)78341-0. Gastroenterol Clin Biol. 2007. PMID: 18176363 Free article.
Changes of non-invasive markers and FibroScan values during HCV treatment.
Vergniol J, Foucher J, Castéra L, Bernard PH, Tournan R, Terrebonne E, Chanteloup E, Merrouche W, Couzigou P, de Lédinghen V. Vergniol J, et al. Among authors: foucher j. J Viral Hepat. 2009 Feb;16(2):132-40. doi: 10.1111/j.1365-2893.2008.01055.x. Epub 2008 Oct 17. J Viral Hepat. 2009. PMID: 19175875
210 results